Chemoinformaics analysis of Cyclohexane, 1-(1,5-Dimethylhexyl)-4-(4-Methylpentyl)-
| Molecular Weight | 280.54 | nRot | 9 |
| Heavy Atom Molecular Weight | 240.22 | nRig | 6 |
| Exact Molecular Weight | 280.313 | nRing | 1 |
| Solubility: LogS | -7.262 | nHRing | 0 |
| Solubility: LogP | 8.385 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 60.0717 |
| nHD | 0 | BPOL | 40.1283 |
| QED | 0.423 |
| Synth | 2.73 |
| Natural Product Likeliness | 0.699 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.053 |
| HIA | 0.002 |
| CACO-2 | -4.579 |
| MDCK | 0.00000888 |
| BBB | 0.098 |
| PPB | 0.968815 |
| VDSS | 3.007 |
| FU | 0.0158727 |
| CYP1A2-inh | 0.064 |
| CYP1A2-sub | 0.216 |
| CYP2c19-inh | 0.268 |
| CYP2c19-sub | 0.722 |
| CYP2c9-inh | 0.188 |
| CYP2c9-sub | 0.961 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.027 |
| CYP3a4-inh | 0.229 |
| CYP3a4-sub | 0.206 |
| CL | 6.681 |
| T12 | 0.023 |
| hERG | 0.12 |
| Ames | 0.004 |
| ROA | 0.031 |
| SkinSen | 0.773 |
| Carcinogencity | 0.037 |
| EI | 0.966 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.51374 |